New Release | Viscosupplementation - Current and Future Players
©
Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability across the globe. Intra-articular viscosupplementation with hyaluronic acid (HA) has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade. Going forward, palliative pain treatments are likely to continue to fare well as healthcare reform kicks in and lag times for knee replacement become the norm. Growth of the viscosupplementation market will be highest in the US and the Asia-Pacific (APAC) region, where there is a significant pent-up demand for early intervention in the management of OA.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=419062
The increasing prevalence of OA and the lower cost of prescribing viscosupplementation compared with knee replacement surgery have prompted the medical community to take a closer look at this therapy. However, there is a growing concern among physicians that the updated American Academy of Orthopaedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will result in increased insurance denials for viscosupplementation. Moving forward, industry consolidation and intense competition in the viscosupplementation arena will cause increasing numbers of companies to augment their research efforts to differentiate their products from the lower-end competitors. The motivation to incorporate the favorable properties of different agents into a more effective viscosupplementation product has led to the manipulation and development of next-generation HA formulations consisting of not only HAs, but also pharmaceuticals, such as corticosteroids.
Highlights
Key Questions Answered
- Because the most prevalent treatment regimen varies from region to region, the competitive landscape in the viscosupplementation space can be quite different across the geographies covered in this report. Who are the leading players in the viscosupplementation market in different countries?
Reasons to buy
- What Do Physicians Think quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Browse Detail Report With TOC @ http://www.researchmoz.us/viscosupplementation-current-and-future-players-report.html
Table of Contents
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Treatment Modalities Overview
3.1 Treatment Paradigm
3.1.1 Physical Therapies
3.1.2 Medications
3.1.3 Hyaluronic Acid Viscosupplementation
3.1.4 Surgical Intervention
4 Competitive Assessment
4.1 Major Viscosupplementation Products
4.1.1 Adant
4.1.2 Arthrum
4.1.3 Curavisc
4.1.4 Durolane
4.1.5 Euflexxa
4.1.6 Fermathron
4.1.7 Gel-One
4.1.8 Go-On
4.1.9 Hyalgan
4.1.10 Hyalubrix and HyalOne
4.1.11 Jonexa
4.1.12 NeoVisc
4.1.13 Orthovisc and Monovisc
4.1.14 Ostenil
4.1.15 Recosyn
4.1.16 RenehaVis
4.1.17 Supartz/ARTZ
4.1.18 Suplasyn
4.1.19 Suvenyl
4.1.20 Synocrom
4.1.21 Synolis V-A
4.1.22 Synovial
4.1.23 Synvisc and Synvisc-One
4.2 Other Viscosupplementation Products
5 Pipeline Products
5.1 Overview
5.2 Gel-Syn (IBSA Institut Biochimique S.A.)
5.3 Cingal (Anika Therapeutics)
5.4 Hydros-TA (Carbylan Therapeutics)
5.5 Additional Indication for Synvisc-One (Sanofi)
5.6 Hymovis (Fidia Farmaceutici S.p.A.)
5.7 HA-NSAID Conjugates (Seikagaku Corporation)
5.8 Additional Indication for Supartz/ARTZ (Seikagaku Corporation)
5.9 Clodronate-HA Conjugates (Abiogen Pharma)
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=419062
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=419062
The increasing prevalence of OA and the lower cost of prescribing viscosupplementation compared with knee replacement surgery have prompted the medical community to take a closer look at this therapy. However, there is a growing concern among physicians that the updated American Academy of Orthopaedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will result in increased insurance denials for viscosupplementation. Moving forward, industry consolidation and intense competition in the viscosupplementation arena will cause increasing numbers of companies to augment their research efforts to differentiate their products from the lower-end competitors. The motivation to incorporate the favorable properties of different agents into a more effective viscosupplementation product has led to the manipulation and development of next-generation HA formulations consisting of not only HAs, but also pharmaceuticals, such as corticosteroids.
Highlights
Key Questions Answered
- Because the most prevalent treatment regimen varies from region to region, the competitive landscape in the viscosupplementation space can be quite different across the geographies covered in this report. Who are the leading players in the viscosupplementation market in different countries?
Reasons to buy
- What Do Physicians Think quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Browse Detail Report With TOC @ http://www.researchmoz.us/viscosupplementation-current-and-future-players-report.html
Table of Contents
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Treatment Modalities Overview
3.1 Treatment Paradigm
3.1.1 Physical Therapies
3.1.2 Medications
3.1.3 Hyaluronic Acid Viscosupplementation
3.1.4 Surgical Intervention
4 Competitive Assessment
4.1 Major Viscosupplementation Products
4.1.1 Adant
4.1.2 Arthrum
4.1.3 Curavisc
4.1.4 Durolane
4.1.5 Euflexxa
4.1.6 Fermathron
4.1.7 Gel-One
4.1.8 Go-On
4.1.9 Hyalgan
4.1.10 Hyalubrix and HyalOne
4.1.11 Jonexa
4.1.12 NeoVisc
4.1.13 Orthovisc and Monovisc
4.1.14 Ostenil
4.1.15 Recosyn
4.1.16 RenehaVis
4.1.17 Supartz/ARTZ
4.1.18 Suplasyn
4.1.19 Suvenyl
4.1.20 Synocrom
4.1.21 Synolis V-A
4.1.22 Synovial
4.1.23 Synvisc and Synvisc-One
4.2 Other Viscosupplementation Products
5 Pipeline Products
5.1 Overview
5.2 Gel-Syn (IBSA Institut Biochimique S.A.)
5.3 Cingal (Anika Therapeutics)
5.4 Hydros-TA (Carbylan Therapeutics)
5.5 Additional Indication for Synvisc-One (Sanofi)
5.6 Hymovis (Fidia Farmaceutici S.p.A.)
5.7 HA-NSAID Conjugates (Seikagaku Corporation)
5.8 Additional Indication for Supartz/ARTZ (Seikagaku Corporation)
5.9 Clodronate-HA Conjugates (Abiogen Pharma)
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=419062
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us